Filing Details

Accession Number:
0001209191-19-028235
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-08 16:35:09
Reporting Period:
2019-05-06
Accepted Time:
2019-05-08 16:35:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293971 Bluebird Bio Inc. BLUE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578696 David Davidson C/O Bluebird Bio, Inc.
60 Binney Street
Cambridge MA 02142
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-06 6,360 $5.50 37,976 No 4 M Direct
Common Stock Disposition 2019-05-06 2,700 $138.25 35,276 No 4 S Direct
Common Stock Disposition 2019-05-06 2,600 $139.24 32,676 No 4 S Direct
Common Stock Disposition 2019-05-06 1,060 $140.02 31,616 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-05-06 6,360 $0.00 6,360 $5.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
330 2023-01-16 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 10, 2019.
  2. The range in prices for the transaction reported on this line was $137.69 to $138.66. The average weighted price was $138.2471. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The range in prices for the transaction reported on this line was $138.70 to $139.69. The average weighted price was $139.2437. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The range in prices for the transaction reported on this line was $139.70 to $140.53. The average weighted price was $140.0164. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. This option to purchase shares of our common stock was granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013, April 1, 2013 and May 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, April 1, 2014 and May 1, 2014, respectively, with the remainder of the shares vesting in equal monthly installments over the following three years.